So, probably 3 years. Quickly?

First 10 Last

Share
Profile

Follow
R.C.

3,851 Posts.

101

21/07/16

00:38

Post #: 18322646
Share

Originally posted by airconditioner ↑

With respect to yourself and those who hold ORE, the simple fact remains that it is unlikely GXY is following ORE into brine to repeat the same trajectory.

From a purely financial perspective - if that path and future was what lay ahead of GXY then they would be deciding on James Bay first, then SDV.
Galaxy is not competing with ORE.
Right now it is a competition between its own remaining assets as to which is the best investment to exploit next - while the lithium iron is so very hot.
SDV must ensure that it out-performs the slow ORE plant ramp-up phase or its simply the less economical road to take right now when we have a potentially excellent asset in James Bay's hard rock plant.

ORE has had several issues - and I'm sure you know all about them as a holder. They come up every time Joe Lowry sticks his head into ORE's business.

This is why GXY has DFS'ed this twice and hunted the best brine minds it can get to run and plan the operation. Anthony Tse has made a point of emphasising the test plant stage as the ultimate key to improving upon the ORE experience. Make sure that staff are trained well. Make sure the build is perfectly executed. Take notes of where ORE's methods have led to disappointing production levels.

At the end of the day it is a chemical plant. The ultimate success is already printed into the salar's percentage of lithium and the amount of its impurities.
SDV's chemistry is what will makes it an easier path to success and should avoid fingers needing to be crossed and many of the complications that ORE has had over achieving a quality battery-grade product. The SDV salar has a higher level of lithium and lower levels of magnesium. Of all the brine deposits that have been tested so far - only one has better chemistry but suffers from being absolutely tiny in comparison.

It's not a matter of the market sustaining a lot of producers.
I'm sure that is true from exploding demand -
but achieving quality and cost efficiency and scale
and above all, for all investors here, the speed with which we reach the production of a high quality battery grade product from a plant that is running to name plate and getting good prices. Quickly.

Expand

So, probably 3 years. Quickly?

GXY Price at posting: 48.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 73 more messages in this thread...

First 10 Last

Add GXY (ASX) to my watchlist

So, probably 3 years. Quickly?

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News